Status:
COMPLETED
Safety and Efficacy of Autologous Cultured Adipocytes in Patient With Depressed Scar
Lead Sponsor:
Anterogen Co., Ltd.
Conditions:
Depressed Scar
Eligibility:
All Genders
19+ years
Phase:
PHASE2
PHASE3
Brief Summary
Autologous cultured adipocytes (ANTG-adip) is produced by well-established techniques including cell harvesting from lipoaspirates, expansion of adipose tissue derived stem cells, and differentiation ...
Eligibility Criteria
Inclusion
- older than 19 years
- depressed scar less than volume of 5 ml
- negative for urine beta-HCG for women of childbearing age
- agreement to participate, with signed informed-consent
Exclusion
- failure to meet inclusion criteria
- any immune-suppressive drug, corticosteroid or cytotoxic drug within the previous 30 days
- allergy to bovine-derived materials
- Diagnosis of cancer, AIDS, HBV or HCV.
- Patient has a lot of hairs or a tattoo on depressed site
- Insufficient adipose tissue for manufacturing of ANTG-adip
- Patient has depressed scar caused by a malignant tumor
- Patient whom investigator consider is not suitable in this study
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00992147
Start Date
May 1 2004
End Date
March 1 2007
Last Update
October 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710